Advanced search×

DNA methylation and cancer: ghosts and angels above the genes.

Nino N Sinčić and Zdenko Z Herceg

Curr Opin Oncol 23(1):69-76 (2011) PMID 21119515

To discuss recent advances in the field of DNA methylation and their impact on our understanding of the role of this epigenetic mechanism in cancer development, as well as their implications for biomarker discovery and therapy.

DOI: 10.1097/CCO.0b013e3283412eb4
Version: za2963e q8za8 q8zbb q8zce q8zd0 q8ze9 q8zf4 q8zgc
Buy PDF

Similar articles you may find interesting…

  1. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Hirofumi Sugita, Satoru Iida, ... Kenichi Sugihara

    Oncol Rep 25(2):513-8 (2011) PMID 21152877

    Aberrant promoter hypermethylation (methylation) is an epigenetic change that silences the expression of crucial genes, thus inactivating the apoptotic pathway in various cancers. Inactivation of the apoptotic pathway has been considered to be associated with chemoresistance. The objective of the pr...
    Buy PDF
  2. Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients.
    Jong Woo Kim, Hye Mi Park, ... Nam Keun Kim

    Oncol Rep 25(1):167-72 (2011) PMID 21109973

    We sought to determine the following: i) genotype frequencies of MTHFR and MTR involved in folate metabolism in cases and cancer-free controls; and ii) the methylation status of three candidate genes (p16INK4A, p73 and hMLH1) in plasma related to the folate and homocysteine levels. From genotype fre...
    Buy PDF